Saturday, 14 December 2019

Singapore gets medical device regulatory curriculum

17 June 2014 | Regulatory | By BioSpectrum Bureau

The program draws on the teaching and research excellence of NUS' biomedical engineering faculty

The program draws on the teaching and research excellence of NUS' biomedical engineering faculty

Singapore: With the objective to enhance regulatory ecosystem in Singapore, Regulatory Affairs Professionals Society (RAPS) and National University of Singapore (NUS) have jointly launched a graduate certificate in Medical Devices Regulatory Affairs (MDRA) program.

The program is intended for Singapore-based regulatory professionals, and was developed in partnership with the government of Singapore to cultivate an industry-ready regulatory workforce.

"Singapore has become an important center for biomedical research and business today," said Sherry Keramidas, executive director, RAPS. "This program will be the first to offer instruction specifically designed to develop the medical device regulatory knowledge that is in high demand by the global companies located there."

The MDRA program builds the foundational knowledge, critical thinking and application skills required of regulatory professionals. The curriculum will be delivered through a combination of online training, interactive seminars, peer interaction and case-based learning, and will cover regulations of ASEAN nations, China, the Asia-Pacific region, the US and Europe.

The program draws on the teaching and research excellence of NUS' biomedical engineering faculty and the real world expertise of RAPS' renowned regulatory leaders from around the world.

Sign up for the editor pick and get articles like this delivered right to your inbox.

Editors Pick
+Country Code-Phone Number(xxx-xxxxxxx)


Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account



Podcast

 

Survey Box

Is APAC region emerging as a leader in assistive technologies?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls